Adicet Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Adicet Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q3 2024.
  • Adicet Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$30.5M, a 38.9% increase year-over-year.
  • Adicet Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$118M, a 17.6% increase year-over-year.
  • Adicet Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$143M, a 104% decline from 2022.
  • Adicet Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$69.8M, a 12.6% decline from 2021.
  • Adicet Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$62M, a 69% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$118M -$30.5M +$19.4M +38.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$137M -$29.9M +$2.5M +7.72% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 -$140M -$28M +$2.87M +9.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 -$143M -$29.5M +$385K +1.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$143M -$49.9M -$27.9M -127% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$115M -$32.4M -$9.87M -43.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$105M -$30.9M -$35.5M -769% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 -$69.8M -$29.9M -$14.1M -88.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$55.7M -$22M -$7.98M -57% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$47.7M -$22.5M -$11.7M -108% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$36.1M $4.62M +$25.9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$62M -$15.8M -$6.86M -76.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$55.1M -$14M +$766K +5.18% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$55.9M -$10.9M -$2.4M -28.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$53.5M -$21.3M -$16.8M -375% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$36.7M -$8.96M +$19.9M +69% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$56.6M -$14.8M -$1K -0.01% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$56.6M -$8.46M -$5.8M -219% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$50.8M -$4.49M -$355K -8.59% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$50.5M -$28.9M -$23.1M -402% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$27.3M -$14.8M -$6.37M -75.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$20.9M -$2.65M +$10.9M +80.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$31.9M -$4.13M +$5.73M +58.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$37.6M -$5.76M +$17.3M +75% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$54.9M -$8.41M -$5.1M -154% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$49.8M -$13.6M -$9.53M -235% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$40.3M -$9.86M -$6.5M -194% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$33.8M -$23.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$3.31M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$4.06M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$3.36M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.